[Biomarkers of carcinogenesis of the upper and lower airway epithelium and the role of chemoprevention].
Lung as well as head and neck cancer represent an important public health problem worldwide, with lung cancer being the leading cause of cancer death in western countries. Although early stage disease is often curable with surgery or radiotherapy, the majority of patients present with advanced disease in which despite advances in combined modality therapy the outcomes have not dramatically improved. Furthermore, patients cured of their initial early stage lung or head and neck carcinoma are at high risk for development of second primary tumors, which pose the main threat to their survival. An alternative approach in reducing the incidence and thus mortality of these cancers is chemoprevention, the use of agents to reverse, halt or delay carcinogenesis. The carcinogenesis process in lung and head and neck cancer results from a dysregulation of cellular proliferation, differentiation and cell death resulting from field-wide exposure of the upper and lower airway track to tobacco smoking. This review article presents main data regarding the actual understanding of lung and head and neck carcinogenesis, as well as results of major chemoprevention trials in this field.
Soria
J C
JC
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Izzo
J
J
Mao
L
L
Hong
W K
WK
Papadimitrakopoulou
V A
VA
D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics*; D002869:Chromosome Aberrations / Q000235:genetics; D002986:Clinical Trials as Topic; D005819:Genetic Markers / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000517:prevention & control; D010039:Otorhinolaryngologic Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000517:prevention & control; D012307:Risk Factors
D016588:Anticarcinogenic Agents; D014408:Biomarkers, Tumor; D005819:Genetic Markers